Monocyte subpopulations of blood and bone marrow in patients with chronic heart failure

Monocyte subpopulations of blood and bone marrow in patients with chronic heart failure

The aim of the investigation was to evaluate the ratio of classical (CD14++CD16-), intermediate (CD14++CD16+), nonclassical (CD14+CD16+) and transient (CD14+CD16–) monocytes in the blood and bone marrow in patients with chronic heart failure (CHF) against ischemic cardiomyopathy (ICMP).Materials and...

Full description

Bibliographic Details
Main Authors:	M. V. Vins, S. P. Chumakova, O. I. Urazova, D. A. Azarova, V. M. Shipulin, A. S. Pryakhin, S. E. Barmina, M. D. Werner, V. V. Novitskiy
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2018-12-01
Series:	Бюллетень сибирской медицины
Subjects:	субпопуляции моноцитов моноцитопоэз хроническая сердечная недостаточность гипоксия ишемическая кардиомиопатия
Online Access:	https://bulletin.ssmu.ru/jour/article/view/1973

Similar Items

Subpopulations of blood monocytes in patients with generalized hypoxia
by: S. P. Chumakova, et al.
Published: (2019-05-01)

EPIDEMIOLOGICAL ASPECTS OF IDIOPATHIC DILATED CARDIOMYOPATHY
by: A. S. Sisakyan, et al.
Published: (2003-08-01)

RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE
by: T. G. Kulikova, et al.
Published: (2015-09-01)

Monocytes and cancer: promising role as a diagnostic marker and application in therapy
by: M. R. Patysheva, et al.
Published: (2019-05-01)

Дисбаланс цитокинов и численность неклассических моноцитов в крови при сердечной недостаточности ишемического генеза
by: В. Шипулин, et al.
Published: (2020-04-01)

The content of hypoxia-inducible factors and mediators of immunosuppression in the blood in diseases associated with hypoxia
by: S. P. Chumakova, et al.
Published: (2020-10-01)

Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

Positive effect of if-channel’s blocker ivabradine therapy in a patient with ischemic chronic heart failure with preserved left ventricle ejection fraction and hereditary thrombophilia (clinical case)
by: Iurii N. Belenkov, et al.
Published: (2019-09-01)

THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

Первый опыт расширенной миоэктомии при хирургическом лечении обструктивной гипертрофической кардиомиопатии: непосредственные и промежуточные результаты
by: А. В. Богачев-Прокофьев, et al.
Published: (2015-10-01)

EARLY MARKERS OF PROGRESSION OF HEART FAILURE AND APOPTOSIS: THEIR ROLE IN PREDICTING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION
by: A. T. Teplyakov, et al.
Published: (2016-03-01)

SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015-12-01)

Differentiation and subpopulation composition of VEGFR2+ cells in the blood and bone marrow in ischemic cardiomyopathy
by: S. P. Chumakova, et al.
Published: (2022-10-01)

Факторы риска возврата митральной недостаточности после аортокоронарного шунтирования и реконструкции митрального клапана у пациентов с ишемической кардиомиопатией
by: Ю. Карева, et al.
Published: (2019-10-01)

FEATURES OF PIRIBEDIL USE IN THE TREATMENT OF MILD COGNITIVE IMPAIRMENTS IN PATIENTS WITH CHRONIC HEART FAILURE
by: N. S. Akimova, et al.
Published: (2015-09-01)

The role of cardiomyocyte apoptosis in mechanisms of ischemic myocardial remodeling
by: A. P. Khlapov, et al.
Published: (2008-09-01)

NON-COMPACT MYOCARDIUM AS A CAUSE OF THE DEVELOPMENT OF CHRONIC HEART FAILURE IN A YOUNG PATIENT
by: Александр Матвеевич Корякин, et al.
Published: (2024-12-01)

CHANGES OF INTERCELLULAR COOPERATION IN PERIPHERAL BLOOD IN TREATED PATIENTS WITH CARDIOLOGIC DISEASES
by: L. N. Korichkina, et al.
Published: (2016-01-01)

KEY PATHOGENETIC ASPECTS AND CLINICAL RELEVANCE OF MECHANICAL DYSSYNCHRONY
by: Yu. V. Stavtseva, et al.
Published: (2015-09-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

Pathogenesis of chronic heart failure: change of dominating paradigm
by: V. V. Kalyuzhin, et al.
Published: (2007-12-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
by: M. V. Melnik, et al.
Published: (2015-12-01)

EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE
by: V. N. Larina, et al.
Published: (2016-01-01)

Systolic longitudinal strain and congestive heart failure in patients with moderate ischemic mitral insufficiency before and after surgical revascularization and mitral annuloplasty
by: С. Г. Суханов, et al.
Published: (2015-10-01)

The non-compact left ventricle cardiomyopathy: clinical features and diagnostic capabilities
by: E. A. Mershina, et al.
Published: (2015-12-01)

Correlative intercoupling of histomorphometrical values of different heart parts in norm and with chronic heart failure
by: V. A. Kazakov, et al.
Published: (2009-06-01)

FEMALE SEX HORMONES AS MODULATORS OF GENDER DIFFERENCES IN RESPONSE TO PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

Mitral valve replacement or repair: choosing optimal surgical treatment of hypertrophic obstructive cardiomyopathy
by: Богачев-Прокофьев А. В., et al.
Published: (2016-01-01)

КАРДИОМИОПАТИЯ ПРИ АТАКСИИ ФРИДРЕЙХА: СОВРЕМЕННЫЕ МЕТОДЫ ДИАГНОСТИКИ
Published: (2021-03-01)

Фармакоэкономический анализ применения левосимендана у больных с тяжёлой декомпенсированной хронической сердечной недостаточностью
Published: (2018-06-01)

ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE
by: L. N. Maksimova, et al.
Published: (2015-09-01)

Mitral valve repair and isolated coronary artery bypass grafting in ischemic cardiomyopathy and moderate mitral insufficiency
by: А. М. Чернявский, et al.
Published: (2015-10-01)

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Russian National Research Medical University named after N.I. Pirogov, Moscow
by: V. N. Larina, et al.
Published: (2015-09-01)

ВЛИЯНИЕ АПОПТОЗА НА ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Ye. N. Berezikova, et al.
Published: (2015-10-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

ОСОБЕННОСТИ МОНОЦИТАРНОГО ОТВЕТА ПРИ ОСТРОМ ИНФАРКТЕ МИОКАРДА У ПАЦИЕНТОВ С САХАРНЫМ ДИАБЕТОМ 2-го ТИПА В ЗАВИСИМОСТИ ОТ ТЯЖЕСТИ ПОРАЖЕНИЯ КОРОНАРНОГО РУСЛА
by: Галина Александровна Кухарчик, et al.
Published: (2022-10-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)